论文部分内容阅读
目的:探究尿激酶溶栓治疗脑血栓的疗效。方法:选取我院2010年5月~2015年5月收治的32例脑血栓患者,将其随机分成观察组和对照组,各16例。观察组通过尿激酶溶栓进行治疗,对照组通过低分子肝素进行治疗,对比两组患者临床治疗效果、神经功能缺损情况。结果:观察组的治疗总有效率93.75%,明显优于对照组62.5%,差异有统计学的意义,P<0.05。观察组的治疗前、治疗后、和对照组神经缺损评分进行对比,差异有统计学的意义,P<0.05。结论:脑血栓患者,通过尿激酶溶栓进行治疗,治疗效果较佳,却可改善患者神经方面的功能缺损情况,值得临床方面应用和推广。
Objective: To investigate the therapeutic effect of urokinase thrombolytic therapy on cerebral thrombosis. Methods: Thirty-two patients with cerebral thrombosis admitted from May 2010 to May 2015 in our hospital were randomly divided into observation group and control group, with 16 cases in each group. The observation group was treated with urokinase thrombolysis, the control group was treated with low molecular weight heparin, and the clinical effects and neurological deficits were compared between the two groups. Results: The total effective rate of the observation group was 93.75%, which was significantly better than that of the control group (62.5%), the difference was statistically significant (P <0.05). Observation group before treatment, after treatment, and the control group compared to the nerve defect score, the difference was statistically significant, P <0.05. Conclusion: Patients with cerebral thrombosis treated by urokinase thrombolysis have better therapeutic effect, but can improve neurological deficits in patients. It is worthy of clinical application and promotion.